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Abstract 
Background: Hyperglycemia and increased levels of methylglyoxal (MGO) can trigger the development of vascular 
complications in diabetes. Resveratrol and quercetin are red wine polyphenols with known beneficial cardiovascular 
properties, including an antioxidant capacity. This study evaluated whether resveratrol and/or quercetin could pre-
vent in vitro-induced diabetic changes in neurogenic and vascular relaxant responses of mouse arteries and corpora 
cavernosa.
Methods: Isometric tension of isolated aorta, mesenteric arteries and corpora cavernosa was measured using organ 
bath systems. Diabetic conditions were mimicked in vitro by co-incubating the tissues for 2 h with high glucose (HG, 
30 mM) and MGO (120 µM).
Results: The presence of HG and MGO significantly blunted acetylcholine (Ach)-induced relaxations in corpora 
cavernosa and mesenteric arteries but not in aorta. Electrical field stimulated (EFS) responses of corpora cavernosa 
were also significantly inhibited by these diabetic conditions. In corpora cavernosa 2 h co-incubation with resveratrol 
(30 µM) or quercetin (30 µM) significantly attenuated HG and MGO-induced deficits in Ach- and EFS-responses.
Conclusions: Our study demonstrates that in mouse arteries, HG and MGO rather affect endothelium derived hyper-
polarizing factor-mediated than nitric oxide (NO)-mediated relaxations. In corpora cavernosa HG and MGO interfere 
with NO release. Resveratrol and quercetin protect mouse corpora cavernosa from diabetic-induced damage to NO-
mediated relaxant responses. This might rely on their antioxidant capacity.
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Background
Hyperglycemia and increased levels of methylglyoxal 
(MGO), a reactive metabolite produced during glyco-
lysis, are two hallmarks of diabetes mellitus which can 
trigger the development of vascular complications in 
diabetes [1–5]. These vascular events are presumed to 
underlie the pathogenesis of diabetic-related erectile dys-
function (ED). Indeed, in different models of diabetes it 
has been demonstrated that neurogenic- and endothe-
lium-mediated relaxation of isolated corpora cavern-
osa [6–10] or arteries [5, 11, 12] is impaired. Moreover, 
in vitro research showed that acute exposure of isolated 
arteries to high glucose (HG) or MGO affects endothe-
lium-dependent relaxations in different vascular beds 
[1, 3, 13–15]. Oxidative stress may play a causative role 
in the damaging effect of hyperglycemia or MGO on 
the endothelium [1, 3, 5, 14, 15]. Therefore, antioxidant 
therapy might offer an option for treating diabetic com-
plications, including ED. Resveratrol and quercetin are 
two naturally occurring polyphenols, mainly present in 
the skin of grapes and thus abundant in red wine. Both 
polyphenols are suggested to have beneficial cardiovas-
cular properties, including a relaxant [16, 17] and antiox-
idant [16, 18, 19] capacity. Recently, our group reported 
a relaxant and antioxidant effect of resveratrol in iso-
lated mouse corpora cavernosa [20]. Considering their 
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antioxidant properties resveratrol and/or quercetin could 
potentially be of value in the treatment of diabetic ED. 
However, the antioxidant effect of these polyphenols in 
mouse mesenteric arteries and corpora cavernosa in dia-
betic conditions is as yet unexplored. Therefore, the aim 
of this study was to evaluate whether resveratrol and/or 
quercetin could protect mouse mesenteric artery and/or 
corpora cavernosa from HG and MGO-induced defects 
in endothelium- and neurogenic-mediated relaxations.
Methods
Animals
Adult (8–12  weeks) male Swiss mice were obtained 
from Janvier (Saint-Berthevin, France). Food and water 
was provided ad  libitum and all animals were treated in 
accordance with the Guide for the Care and Use of Labo-
ratory Animals published by the US National Institutes 
of Health. This study was approved by the local Ethical 
Committee for Animal experiments, Faculty of Medicine 
and Health Sciences, Ghent University, Belgium.
Tissue preparation
After cervical dislocation, thoracic aorta, mesenteric 
arteries (1st and 2nd order) and corpora cavernosa were 
carefully isolated and dissected free from surrounding 
structures. All tissues were kept in cold Krebs–Ringer 
bicarbonate (KRB) solution. Aorta and mesenteric arteries 
were cut into rings of about 3 mm in length and mounted 
in a wire myograph for isometric tension measurements. 
Of each mouse, one corpora cavernosa was mounted 
horizontally in a myograph with one end fixed to a trans-
ducer and the other to a micrometer. The tissue chambers 
were filled with 10  mL KRB solution at 37  °C (pH 7.4) 
equilibrated with 95  % O2–5  % CO2. The preparations 
were allowed to equilibrate for 30  min in KRB solution 
that was frequently replaced. In order to obtain maximal, 
stable contractions and relaxations, mesenteric arter-
ies were stretched to their optimal lumen diameter that 
gives a maximum response, as calculated on the basis of 
the passive wall tension-internal circumference relation-
ship [21]. Aorta segments and corpora cavernosa were 
gradually stretched until a stable preload of 0.5 g (aorta) 
or 0.45 g (corpora cavernosa) was obtained. Subsequently, 
tissues were repeatedly activated using different proto-
cols: (1) aorta with 120 mM K+ and 1 µM phenylephrine 
(Phe) (2) mesenteric arteries three times with 120 mM K+ 
and 10 µM Phe and (3) corpora cavernosa two times with 
5 µM Phe. The integrity of the endothelium was examined 
by contracting the tissues with submaximal Phe concen-
trations (1 µM for aorta, 5 µM for corpora cavernosa and 
10  µM for mesenteric arteries) and adding acetylcholine 
(Ach) (10 µM for arteries or 1 µM for corpora cavernosa). 
Only tissues that relaxed more than 50  % to Ach, were 
included in this study.
Experimental protocol
Tissues were incubated for 2 h with: (1) control KRB solu-
tion containing 10 mM glucose or (2) KRB solution con-
taining 30  mM glucose (HG) and 120  µM MGO. Every 
30 min the KRB solution in the organ baths was refreshed. 
After 2  h incubation, tissues were precontracted with 
Phe (1–10  µM). Firstly, the relaxant effect of resveratrol 
(1–100  µM) and quercetin (1–100  µM) was evaluated. 
Secondly, the protective effect of resveratrol and quercetin 
on endothelium-(in) dependent relaxations were evalu-
ated. Relaxant responses to Ach (1 nM to 1 or 10 µM) and 
sodium nitroprusside (SNP) (1 nM–1 µM), were examined 
after 2 h pretreatment with 30 mM glucose and 120 µM 
MGO in absence or presence of ascorbic acid (100  µM), 
tempol (100 µM), resveratrol (30 µM) or quercetin (10 or 
30 µM). In corpora cavernosa, neurogenic-mediated relax-
ations were also studied by applying electrical field stim-
ulation (EFS; parameters: train duration 40  s; 1, 2, 4 and 
8 Hz; pulse duration 5 min and 80 V).
Drugs and chemicals
The experiments were performed in a KRB solution 
of the following composition (mM): NaCl 135, KCl 5, 
NaHCO3 20, glucose 10 (control) or 30 (HG), CaCl2 2.5, 
MgSO4 1.3, KH2PO4 1.2 and EDTA 0.026 in H2O. l-phe-
nylephrine hydrochloride (Phe), acetylcholine chloride 
(Ach), SNP, Nω-Nitro-l-arginine methyl ester hydrochlo-
ride (L-NAME), indomethacin (indo), MGO solution, 
4-hydroxy-tempo (Temp), l-ascorbic acid  (AA), res-
veratrol, quercetin and dimethylsulfoxide (DMSO) were 
obtained from Sigma (St. Louis, MO). Stock solutions 
were made in water except for indo (ethanol). The final 
concentrations of vehicle solution in the organ bath never 
exceeded 0.1  %. Stock solutions of 100  mM of resvera-
trol and quercetin were made in DMSO, but were further 
diluted in distilled water (10  mM) before adding to the 
organ baths.
Statistics
The data are presented as mean values ±  SEM. Relaxa-
tions are expressed as % decrease in precontractile tone. 
N is the number of individual strips/rings used. Sensitiv-
ity (pD2) and maximum response (Emax) were calculated 
from the concentration–response curves to resvera-
trol, quercetin or acetylcholine. pD2 was defined as the 
negative logarithm to base 10 of the EC50 values and 
Emax was defined as the maximal relaxation. The data 
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were analysed using SPSS, version 22; IBM Corporation, 
Armonk, NY, USA. Statistical significance was evaluated 
using the Mann–Whitney U test. Two groups of data 
were considered significantly different when p  <  0.05. 
Graphs were created using Graphpad Prism, version 4.00, 
GraphPad Software, San Diego California USA.
Results
Relaxant capacity of resveratrol and quercetin in presence 
of HG and MGO
Both resveratrol and quercetin (1–100  µM, 15  min) 
relaxed Phe-precontracted aortic and mesenteric 
rings concentration dependently (Fig.  1a, b). Maxi-
mal relaxation for resveratrol was 74.4  ±  5.1  % (aorta) 
and 101.8  ±  2.0  % (mesenteric arteries); pD2 values 
were 4.4 ±  0.1 and 4.9 ±  0.1 for aortic and mesenteric 
rings respectively. Maximal relaxation for quercetin 
was 59.0  ±  11.1  % (aorta) and 102.8  ±  4.3  % (mesen-
teric arteries); pD2 values were 4.5 ±  0.1 and 5.4 ±  0.1 
for aortic and mesenteric rings respectively. In contrast, 
only resveratrol evoked concentration dependent relaxa-
tions in corpora cavernosa (Emax: 50.6 ± 9.6 % and pD2: 
4.9  ±  0.5) (Fig.  1c). Based on these results, following 
concentrations of resveratrol and quercetin were chosen 
for our subsequent experiments: 10  µM resveratrol and 
3  µM quercetin for mesenteric arteries, 30  µM resvera-
trol and 30 µM quercetin for corpora cavernosa.
HG and MGO impair Ach‑ and EFS‑relaxations
Endothelium-dependent relaxations where evaluated 
using Ach (1 nM to 1 or 10 µM), which induced concen-
tration dependent relaxations in all tissues. To explore 
the role of endothelium derived hyperpolarizing factor 
(EDHF), Ach-curves were constructed in presence of 
the NO synthase inhibitor, L-NAME (0.1  mM, 20  min), 
and the cyclooxygenase blocker, indo (10  µM, 20  min). 
The presence of L-NAME and indo completely abolished 
Ach-relaxations in aorta and corpora cavernosa, whereas 
these inhibitors did not affect Ach-relaxations of mesen-
teric arteries (data not shown).
After 2  h incubation with HG (30  mM) and MGO 
(120  µM), Ach-induced relaxations were significantly 
blunted in mesenteric arteries (Fig.  2a, b) and corpora 
cavernosa (Fig. 2c, d). EFS-relaxations of corpora caver-
nosa were significantly reduced by 2  h exposure to HG 
(30 mM) and MGO (120 µM) (Fig. 2e, f ).
In contrast, the presence of 30 mM glucose and 120 µM 
MGO neither affected Ach-relaxations of aorta (Fig. 3a) 
nor SNP-relaxations of aorta, mesenteric arteries or cor-
pora cavernosa (Fig. 3b–d).
Fig. 1 (Vaso)relaxant effect of resveratrol or quercetin in presence of high glucose and methylglyoxal. a Aorta, b mesenteric artery and c corpora 
cavernosa. Tissues were incubated for 2 h with 30 mM glucose (HG) and 120 µM methylglyoxal (MGO) before constructing concentration–response 
(1–100 µM) curves to resveratrol (Res, 15 min) or quercetin (Quer, 15 min). Data are expressed as % decrease of Phe-induced tone; Mann–Whitney U 
test; #p < 0.01 and *p < 0.05 (vehicle control vs. Res) (n = 5–6); ##p < 0.01 and **p < 0.05 (vehicle control vs. Quer) (n = 5–6)
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Role of oxidative stress in glucose and MGO‑impaired 
relaxations
Mesenteric arteries and corpora cavernosa were pre-
treated for 2  h with 30  mM glucose and 120  µM MGO 
in combination with the antioxidant AA (100 µM) or the 
superoxide anion scavenger Temp (100  µM). In mesen-
teric arteries both AA (Fig.  4a) and Temp (Fig.  5a) pre-
vented glucose and MGO impairment of Ach-relaxations. 
Neither AA nor Temp altered sensitivity to Ach, whereas 
maximal Ach-responses were improved in presence of 
AA or Temp (Table  1). Similarly, in corpora cavernosa, 
both antioxidants counteracted the effect of glucose and 
MGO incubation on Ach- and EFS-responses (Figs.  4b, 
c and 5b, c). pD2 values were unaltered by antioxi-
dant treatment. Maximal Ach-responses were however 
improved in presence of AA or Temp (Table 1).
Fig. 2 Effect of in vitro-diabetic conditions on acetylcholine and electrical field stimulated responses of mesenteric artery and corpora cavernosa. 
Original tracings showing the effect of 2 h incubation with high glucose (HG, 30 mM) and methylglyoxal (MGO, 120 µM) on (a–d) acetylcholine 
(Ach, −log M) and e, f electrical field stimulated (Hz) relaxations of mesenteric artery and corpora cavernosa after precontraction with phenyle-
phrine (Phe; 10 µM for mesenteric arteries; 5 µM for corpora cavernosa). Response curve to Ach in mesenteric artery in (a) absence and (b) presence 
of HG and MGO; in corpora cavernosa in (c) absence and (d) presence of HG and MGO. EFS-relaxations in corpora cavernosa in (e) absence and (f) 
presence of HG and MGO
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Effect of resveratrol and quercetin on glucose 
and MGO‑impaired relaxations
In mesenteric arteries, Ach-induced relaxations were 
explored after 2  h pretreatment with 30  mM glucose 
and 120 µM MGO in combination with resveratrol (Res, 
10  µM, 2  h) or quercetin (Quer, 3  µM, 2  h). Neither 
resveratrol (Fig.  6a) nor quercetin (Fig.  7a) prevented 
glucose and MGO impairment of Ach-relaxations as nei-
ther Emax nor pD2 values were affected by resveratrol or 
quercetin treatment (Table  1). On the contrary, expos-
ing the corpora cavernosa for 2 h to 30 mM glucose and 
120  µM MGO in combination with resveratrol (30  µM, 
2  h) or quercetin (30  µM, 2  h) significantly corrected 
blunted Ach- and EFS-relaxations (Figs. 6b, c and 7b, c). 
Emax values were significantly corrected by resveratrol as 
well as by quercetin treatment (Table 1). No effect of both 
polyphenols was found on the potency of Ach as pD2 val-
ues were unchanged by resveratrol or quercetin addition 
(Table 1).
Discussion
The present study was the first to demonstrate that 
co-incubation of mouse mesenteric arteries and cor-
pora cavernosa with 30 mM glucose and 120 µM MGO 
causes deficits in endothelium- and neurogenic-mediated 
relaxations. In addition, resveratrol and quercetin were 
effective in preventing diabetic-induced deficits in cor-
pora cavernosa.
Diabetic (neuro)vascular damage induced by in vitro HG 
and MGO treatment
The concentrations of glucose and MGO used in our 
study were chosen based on literature. 30  mM glucose 
is a level that is found or even exceeded in the blood of 
db/db mouse model of type 2 diabetes that is associated 
with severe endothelial dysfunction in the small mesen-
teric arteries [22]. In addition, in patients with poorly 
controlled diabetes, the MGO level in blood can raise up 
to 400 µM [23]. Moreover, exogenous MGO is not fully 
absorbed intracellularly [24]. Therefore the use of 30 mM 
glucose and 120 µM MGO in this study seems to be jus-
tified as these concentrations seem pathophysiologically 
relevant.
The effect of either glucose or MGO on endothelium-
dependent relaxations has been investigated in several 
studies [1, 3, 5, 13, 15], however no study has evaluated 
the joint effect of MGO and elevated glucose in mouse 
mesenteric arteries or corpora cavernosa. Since both glu-
cose and MGO levels are increased in diabetes mellitus 
[4, 23], diabetic conditions are more precisely mimicked 
Fig. 3 Effect of in vitro-diabetic conditions on acetylcholine and sodium nitroprusside responses of aorta, mesenteric artery and corpora cavernosa. 
Acetylcholine (Ach)-induced relaxations of mouse (a) aorta and on sodium nitroprusside (SNP)-induced relaxations of (b) aorta, c mesenteric artery 
and d corpora cavernosa after 2 h incubation with high glucose (HG, 30 mM) and methylglyoxal (MGO, 120 µM) after precontraction with Phe (1 µM 
for aorta, 10 µM for mesenteric arteries and 5 µM for corpora cavernosa). Data are expressed as % decrease of Phe-induced tone; Mann–Whitney U 
test; (n = 7–8 for Ach-curves) (n = 4–6 for SNP-curves)
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in  vitro by co-incubating the tissues with both com-
pounds. Our results are in line with previous studies 
showing a negative effect of HG or MGO on endothe-
lium-dependent relaxations in mesenteric arteries of rats 
or mice [1, 13–15]. In addition, the impaired endothe-
lium- and neurogenic-mediated relaxations observed in 
corpora cavernosa are in agreement with studies using 
other animal models for diabetes [6–10]. It thus seems 
that the in  vitro glucose/MGO treatment used in this 
study indeed yields neurovascular damage as observed 
in  vivo in diabetes mellitus. Confirming most of these 
studies, relaxant responses to SNP, an endothelium-
independent nitric oxide (NO) donor, were unaltered 
by exposing the tissues to HG and MGO. Thus neither 
a diminished response at the level of the smooth muscle 
cells nor defects in the cyclic guanosine monophosphate 
pathway can explain the observed diabetic-induced defi-
cits of Ach- and EFS-relaxations. Instead, these deficits 
will thus rather result from decreased synthesis and/
or increased quenching of endothelium- or neuronal-
derived relaxing factors by HG and MGO.
Aorta versus mesenteric arteries
No effect of diabetic conditions was found on Ach-relax-
ations in aorta, which is in contrast to Dhar et al. [3], who 
found a decreased Ach response in rat aorta after incu-
bation with 25  mM glucose. As in our study a trend in 
reduced Ach-relaxations of aorta could be observed, it is 
possible that the incubation time of glucose/MGO was 
too short to cause endothelial damage. With respect to 
the arteries used in this study, our results indicate that 
diabetic conditions affect endothelium-mediated relaxa-
tions in mesenteric arteries more rapidly than in aorta. 
This implies that the type of artery and/or the lumen 
diameter determines the effect of glucose/MGO on 
Ach-induced relaxations. Ach stimulates the release of 
endothelium derived relaxing factors: NO, prostacyc-
lin and EDHF. Different vascular beds exhibit a marked 
Fig. 4 Ascorbic acid prevents high glucose and methylglyoxal-induced deficits in mesenteric artery and corpora cavernosa. Acetylcholine (Ach)-
induced relaxations of a mesenteric artery and b corpora cavernosa after 2 h co-incubation with high glucose (HG, 30 mM) and methylglyoxal 
(MGO, 120 µM) in absence and presence of ascorbic acid (AA, 100 µM) after precontraction with Phe (10 µM for mesenteric arteries; 5 µM for 
corpora cavernosa). c Electrical field stimulated (EFS) relaxations of corpora cavernosa after 2 h incubation with high glucose (HG, 30 mM) and 
methylglyoxal (MGO, 120 µM) in absence and presence of ascorbic acid (AA, 100 µM). Data are expressed as % decrease of Phe-induced tone; 
Mann–Whitney U test; #p < 0.01 and *p < 0.05 (n = 5–7)
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heterogeneity in the relative contribution of these fac-
tors to endothelium-dependent relaxations [25]. Indeed, 
inhibition of NO and prostacyclin production (using 
L-NAME and indo respectively) did not affect Ach-relax-
ations in mesenteric arteries whereas the presence of 
these inhibitors completely abolished Ach-responses in 
aorta. This demonstrates that Ach-relaxations in mesen-
teric arteries are EDHF-mediated [11, 25] while in aorta 
these are NO-mediated. Thus, in mouse arteries HG and 
MGO seem to interfere more rapidly with EDHF- than 
with NO-dependent relaxations.
Corpora cavernosa
Like in aorta, Ach- and EFS-relaxations of corpora cav-
ernosa are NO-mediated (own observations and [9, 26]). 
However, unlike in aorta, these NO-mediated relaxa-
tions are inhibited by co-incubating the corpora caver-
nosa with 30 mM glucose and 120 µM MGO. So, besides 
Fig. 5 Tempol prevents high glucose and methylglyoxal-induced deficits in mesenteric artery and corpora cavernosa. Acetylcholine (Ach)-induced 
relaxations of a mesenteric artery and b corpora cavernosa after 2 h incubation with high glucose (HG, 30 mM) and methylglyoxal (MGO, 120 µM) 
in absence and presence of tempol (Temp, 100 µM) after precontraction with Phe (10 µM for mesenteric arteries; 5 µM for corpora cavernosa). c 
Electrical field stimulated (EFS) relaxations of 5 µM Phe-precontracted mouse corpora cavernosa after 2 h incubation with high glucose (HG, 30 mM) 
and methylglyoxal (MGO, 120 µM) in absence and presence of tempol (Temp, 100 µM). Data are expressed as % decrease of Phe-induced tone; 
Mann–Whitney U test; #p < 0.01 and *p < 0.05 (n = 5–6)
Table 1 Effect of  antioxidants and  polyphenol treat-
ment on  acetylcholine-relaxations of  mesenteric arteries 
and corpora cavernosa
pD2 −log(EC50), Emax maximal relaxation response, HG high glucose (30 mM), 
MGO methylglyoxal (120 µM), AA ascorbic acid (100 µM), Temp tempol (100 µM), 
Res resveratrol (10 µM for mesenteric arteries, 30 µM for corpora cavernosa), 
Quer quercetin (3 µM for mesenteric arteries; 30 µM for corpora cavernosa). Data 
are mean ± SEM. * p < 0.05; #p < 0.01 (compared to HG + MGO group)
Mesenteric arteries Corpora cavernosa
pD2 Emax (%) pD2 Emax (%)
HG + MGO
HG + MGO + AA
7.1 ± 0.4
7.0 ± 0.2
19.8 ± 2.6
46.8 ± 4.8#
7.8 ± 0.1
7.8 ± 0.2
35.8 ± 6.4
83.5 ± 6.1*
HG + MGO
HG + MGO + Temp
7.0 ± 0.3
7.1 ± 0.1
23.9 ± 5.04
58.3 ± 4.4#
7.7 ± 0.1
7.9 ± 0.2
38.7 ± 4.2
74.3 ± 3.5#
HG + MGO
HG + MGO + Res
6.3 ± 0.9
6.7 ± 0.5
23.2 ± 5.0
34.8 ± 3.7
7.7 ± 0.3
7.6 ± 0.2
47.6 ± 4.3
83.8 ± 4.6#
HG + MGO
HG + MGO + Quer
7.4 ± 1.0
6.7 ± 0.2
24.4 ± 4.4
31.3 ± 6.3
7.9 ± 0.3
7.9 ± 0.02
44.9 ± 3.5
80.0 ± 5.5#
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the lumen diameter of the vessels, the type of tissue also 
contributes to the effect of diabetic conditions on relax-
ant responses to Ach or EFS. Since unaltered aortic 
Ach-relaxations were observed in presence of HG and 
MGO, it can be assumed that (1) these diabetic condi-
tions induce less damage in aorta or (2) the aorta is more 
resistant to changes evoked by glucose/MGO. As previ-
ously mentioned, our results cannot rule out that longer 
exposure to HG/MGO could yield similar endothelial 
damage in aorta as seen in corpora cavernosa or mesen-
teric arteries. However, based on our results it seems that 
both corpora cavernosa and mesenteric arteries are more 
prone to diabetic-induced endothelial and/or neurogenic 
changes compared to large arteries such as aorta.
Oxidative stress as underlying cause of in vitro‑diabetic 
damage
A hyperglycemia or MGO-dependent increase in reac-
tive oxygen species (ROS) [1, 3, 5, 14, 15] seems to be 
an important contributor to the pathogenesis of the 
diabetic-(neuro)vascular complications. After all, anti-
oxidant administration can limit oxidative damage and 
restore diabetes-induced defects in endothelial- and/or 
neurogenic responses of arteries [27–29] or corpora cav-
ernosa [7–10]. Here we demonstrate that the antioxidant 
AA or the superoxide anion scavenger Temp markedly 
inhibit glucose/MGO-induced damage to endothelium- 
and neurogenic-mediated responses of mesenteric arter-
ies and corpora cavernosa. Despite the large amount of 
evidence for HG or MGO-induced oxidative stress, the 
mechanisms whereby ROS formation is induced, are not 
fully understood. Recently it was reported that MGO-
stimulated ROS production activates the endothelial 
plasma membrane transport protein, Na+/H+ exchanger 
(NHE1) [30]. Moreover HG-induced vascular deficits 
are related to hyperactivity of NHE1 [31]. Activation of 
NHE1 may thus be a critical step for ROS-induced dam-
age. Regardless of the mechanism by which glucose/
Fig. 6 Effect of resveratrol on high glucose and methylglyoxal-induced deficits in mesenteric artery and corpora cavernosa. Acetylcholine (Ach)-
induced relaxations of a mesenteric artery and b corpora cavernosa after 2 h incubation with high glucose (HG, 30 mM) and methylglyoxal (MGO, 
120 µM) in absence and presence of resveratrol (Res, 10 µM for a; 30 µM for b) after precontraction with Phe (10 µM for mesenteric arteries; 5 µM 
for corpora cavernosa). c Electrical field stimulated (EFS) relaxations of 5 µM Phe-precontracted mouse corpora cavernosa after 2 h incubation with 
high glucose (HG, 30 mM) and methylglyoxal (MGO, 120 µM) in absence and presence of resveratrol (Res, 30 µM). Data are expressed as % decrease 
of Phe-induced tone; Mann–Whitney U test; #p < 0.01 and *p < 0.05 (n = 5–7)
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MGO generate oxidative stress, our results indicate that 
ROS, including superoxide anion, interfere with the 
NO-pathway, in corpora cavernosa, or the EDHF-path-
way, in mesenteric arteries, leading to impaired Ach- 
and EFS-relaxations. Although not addressed in this 
study, ROS interference with the NO-pathway involves 
either decreased NO synthesis or increased NO deg-
radation. Increased oxidative stress leads to the oxida-
tion of tetrahydrobiopterin (BH4), a cofactor that tightly 
regulates NO production, resulting in the uncoupling of 
endothelial NO synthase (eNOS) [32, 33]. In the pres-
ence of reduced concentrations of BH4, eNOS transfers 
electrons to molecular oxygen instead of l-arginine to 
produce superoxide rather than NO [32, 33]. In addi-
tion superoxide itself can react and consume NO, form-
ing peroxynitrite and thus enhancing oxidative stress. 
Hence, NO-mediated relaxations are further impaired. 
On the contrary, less is known about the interference 
of oxidative stress with the EDHF-pathway. Impaired 
EDHF-responses due to increased oxidative stress does 
not result from altered K+ channel function [15]. ROS-
induced altered interaction between cAMP and gap 
junctions communication might represent another expla-
nation [15].
Resveratrol and quercetin in diabetic conditions
Numerous health benefits have been ascribed to the 
red wine polyphenols resveratrol and quercetin [16]. 
Even in diabetic rats these polyphenols restore impaired 
endothelium-dependent relaxations of aorta [34–36] and 
improve erectile function [37–40]. In addition, studies 
have reported a direct anti-diabetic effect of resveratrol 
and quercetin as they were able to lower blood glucose 
levels in diabetic rats and mice [41, 42]. In this study 
resveratrol and quercetin administration prevented glu-
cose/MGO-induced damage to endothelium- and neuro-
genic-induced relaxations in corpora cavernosa. This is 
in line with Murat et al. [43] who found that resveratrol 
Fig. 7 Effect of quercetin on high glucose and methylglyoxal-induced deficits in mesenteric artery and corpora cavernosa. Acetylcholine (Ach)-
induced relaxations of a mesenteric artery and b corpora cavernosa after 2 h incubation with high glucose (HG, 30 mM) and methylglyoxal (MGO, 
120 µM) in absence and presence of quercetin (Quer, 3 µM for a; 30 µM for b) after precontraction with Phe (10 µM for mesenteric arteries; 5 µM 
for corpora cavernosa). c Electrical field stimulated (EFS) relaxations of 5 µM Phe-precontracted mouse corpora cavernosa after 2 h incubation with 
high glucose (HG, 30 mM) and methylglyoxal (MGO, 120 µM) in absence and presence of quercetin (Quer, 30 µM). Data are expressed as % decrease 
of Phe-induced tone; Mann–Whitney U test; #p < 0.01 and *p < 0.05 (n = 4–7)
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protects and restores endothelium-dependent relaxation 
in hypercholesterolemic rabbit corpus cavernosum. On 
the contrary, in mesenteric arteries no protective effect 
of resveratrol or quercetin was found. Different explana-
tions could clarify this tissue specific effect of both poly-
phenols. First, studies pointed out that resveratrol and 
quercetin stimulate endothelial NO production [16, 17, 
19]. As endothelial- and neurogenic relaxant responses in 
corpora cavernosa are NO-mediated, enhanced endothe-
lial or neuronal NO synthesis by the polyphenols could 
clarify the improved Ach-relaxations. In contrast this 
could not explain the inability of resveratrol and querce-
tin to protect mesenteric arteries from diabetic-damage 
to Ach-responses. We have shown that Ach-induced 
relaxations in mesenteric arteries are EDHF mediated. 
Nonetheless, one could expect that if resveratrol and 
quercetin enhance endothelial NO production this could 
compensate for decreases in EDHF-responses, result-
ing in improved Ach-relaxations. However this was not 
the case. Moreover in a previous study [20] we found 
that resveratrol relaxes mouse corpora cavernosa inde-
pendent of the endothelium or NO. In addition we also 
demonstrated that neither resveratrol nor quercetin 
stimulated Ach-relaxations of mouse corpora cavernosa 
as such [20]. Therefore improved NO production can-
not explain why the protective effect of resveratrol and 
quercetin against glucose/MGO-induced damage is lim-
ited to the corpora cavernosa.
Recently it was suggested that K+ channel activation 
could also be involved in resveratrol’s positive effects on 
the cardiovascular system [44], including in resveratrol’s 
relaxant effect on corpora cavernosa [45]. In our study 
there is no evidence to strengthen this idea, as we pre-
viously found that resveratrol relaxes mouse corpora 
cavernosa independent of K+ channel activation [20]. 
Furthermore this could not explain the protective effect 
of quercetin on EFS- and Ach-relaxations in corpora cav-
ernosa, since quercetin was not able to relax mouse cor-
pora cavernosa.
Another explanation for the positive effects of resvera-
trol and quercetin in corpora cavernosa and not in mes-
enteric arteries, could be found in the different amount 
of oxidative stress that is induced by the glucose/MGO 
treatment. Since in mesenteric arteries Ach-relaxations 
were almost completely abolished by HG and MGO, it 
is possible that the degree of generated oxidative stress 
is too high for resveratrol or quercetin to cope with. It 
is for instance suggested that the protective effects of 
resveratrol against oxidative injury are attributed to up-
regulations of the endogenous cellular antioxidant system 
rather than to its direct ROS scavenging activity, as it is 
known that the direct antioxidant effect of resveratrol is 
rather low [16]. However both polyphenols are as effi-
cacious as known antioxidants to attenuate diabetic-
induced oxidative endothelial damage. In addition, in 
diabetic-mimicking conditions resveratrol has a direct 
relaxant effect as in the present study resveratrol relaxed 
corpora cavernosa concentration-dependently in pres-
ence of glucose/MGO. Taken together, these results thus 
suggest a potential therapeutic role for both polyphenols, 
but especially for resveratrol, in the treatment of diabe-
tes- and oxidative stress-associated ED.
Limitations
As this study represents a strictly pharmacological 
in vitro approach, it is hard to extrapolate our results to 
in  vivo circumstances. Although some studies already 
pointed out that polyphenols in vivo have positive effects 
on vascular [16] or erectile function [37, 39, 46], further 
research in this field is definitely required. Furthermore, 
in our study only the acute effect of glucose/MGO and 
resveratrol and quercetin administration could be evalu-
ated. Further research will have to confirm whether 
a similar positive effect on erectile function can be 
obtained after chronic treatment.
Conclusions
This study demonstrates that HG in combination with 
MGO impairs endothelium- and neurogenic-mediated 
relaxations in mouse corpora cavernosa and mesenteric 
arteries which is prevented by antioxidants. In arteries, 
these diabetic conditions primarily affect the EDHF-
pathway, while in corpora cavernosa HG and MGO 
interfere with NO release. Furthermore it was shown 
that resveratrol and quercetin are effective in preventing 
HG and MGO deficits of endothelium- and neurogenic-
mediated relaxations of mouse corpora cavernosa. There-
fore our study further strengthens the strategy of using 
polyphenols, especially resveratrol, as possible alternative 
option in the treatment of diabetic ED.
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